Fevertree Cancels 15,871 Shares After Latest Buyback on LSE

Fevertree Drinks ( (GB:FEVR) ) just unveiled an update.

Fevertree Drinks plc has repurchased 15,871 of its own ordinary shares on 4 March 2026 through broker Investec Bank at prices between 895p and 920p, with a volume-weighted average price of 906.5795p. The company plans to cancel these shares, slightly reducing its share capital and potentially enhancing earnings per share and shareholder value without altering its operating strategy.

The buyback was executed on the London Stock Exchange’s main market, with all trades conducted in compliance with U.K. Market Abuse Regulation requirements. This transaction forms part of a wider shareholder-authorised repurchase programme, signalling continued capital management discipline and confidence in the company’s equity valuation.

The most recent analyst rating on (GB:FEVR) stock is a Hold with a £1030.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.

Spark’s Take on GB:FEVR Stock

According to Spark, TipRanks’ AI Analyst, GB:FEVR is a Outperform.

Fevertree Drinks’ overall stock score is primarily driven by its strong financial performance and positive corporate events, particularly the share buyback program. However, the high valuation and mixed technical indicators slightly offset these strengths. The absence of recent earnings call data limits the assessment of forward-looking guidance and sentiment.

To see Spark’s full report on GB:FEVR stock, click here.

More about Fevertree Drinks

Fevertree Drinks plc, known under the Fever-Tree brand, operates in the beverages industry, focusing on premium carbonated mixers such as tonics and sodas. The company targets both on-trade and off-trade channels, supplying bars, restaurants, and retailers in the U.K. and internationally as a leading player in the premium mixer segment.

Average Trading Volume: 287,147

Technical Sentiment Signal: Hold

Current Market Cap: £1.04B

See more insights into FEVR stock on TipRanks’ Stock Analysis page.